Table 1 Patient characteristics
Patients | Overall (N = 61) | High-risk (N = 20) | Low-risk (N = 41) | P value |
|---|---|---|---|---|
Male | 42 (68.9) | 15 (75.0) | 27 (65.9) | 0.464 |
Age, years | 74.7 ± 12.9 | 77.5 ± 11.4 | 73.3 ± 13.4 | 0.230 |
Hypertension | 38 (62.2) | 12 (60.0) | 26 (63.4) | 0.797 |
Diabetes mellitus | 42 (68.9) | 13 (65.0) | 29 (70.7) | 0.652 |
Dyslipidemia | 32 (52.5) | 9 (45.0) | 23 (56.1) | 0.415 |
Smoker | 16 (26.2) | 6 (30.0) | 10 (24.4) | 0.642 |
Hemodialysis | 33 (54.1) | 12 (60.0) | 21 (51.2) | 0.517 |
Coronary artery disease | 26 (42.6) | 10 (50.0) | 16 (39.0) | 0.417 |
Stroke | 11 (18) | 6 (30.0) | 5 (12.2) | 0.098 |
Left ventricular ejection fraction (LVEF), % | 62.3 ± 13.8 | 61.6 ± 14.8 | 62.7 ± 13.4 | 0.781 |
Reduced LVEF < 45% | 10 (16.4) | 4 (20.0) | 6 (14.6) | 0.60 |
Albumin (g/dl) | 3.26 ± 0.59 | 3.10 ± 0.63 | 3.35 ± 0.55 | 0.116 |
Dual anti-platelet therapy | 23 (37.8) | 9 (45.0) | 14 (34.2) | 0.414 |
Anticoagulant therapy | 15 (24.6) | 6 (30.0) | 9 (22.0) | 0.498 |
Statin user | 27 (44.2) | 8 (40.0) | 19 (46.3) | 0.639 |
Body mass index, kg/m2 | 19.8 ± 3.8 | 18.1 ± 2.7 | 20.6 ± 4.1 | 0.02 |
Non-ambulatory | 27 (44.3%) | 16 (80.0) | 11 (26.8) | < 0.0001 |
Follow-up period, days | 268 ± 110 | 223 ± 125 | 291 ± 97 | 0.024 |